Initial media reports suggest how timely interventions by various official agencies in Odisha prevented loss of human lives when Cyclone Fani hit that state on 3rd May. However, it is essential to also take into account recent official reports by different agencies, which indicate that the impact of the cyclone has been quite severe. A situation assessment report on the impact of Fani cyclone dated 15th May, 2019, which was released...

-Newsclick.in Even as a strong campaign against PepsiCo products began in India, the corporate giant said it might withdraw the case if farmers were willing to sign an agreement for buying the registered variety of FC-5 potato seeds. New Delhi: The legal tussle between multinational giant PepsiCo and potato farmers in India has intensified. In a court hearing in Ahmedabad on April 26, the company has gone ahead to suggest an...

-The Indian Express On a suit filed by PepsiCo India Holdings Pvt Ltd, the Ahmedabad city civil court earlier this month had barred four farmers of Sabarkantha district — Bipin Patel, Chhabil Patel, Vinod Patel and Haribhai Patel — from growing and selling potatoes till April 26. Ahmedabad: Leading rights groups and individuals working for farmers’ rights in the country have sought Central government’s intervention to protect at least nine farmers...

-Down to Earth Illegal mining has ravaged the mountain range in the past few decades. Down To Earth investigates the loss and traces the legal developments in Rajasthan, Haryana and Delhi Abdal khan is a prisoner of geography. A resident of Nimli village in Rajasthan’s Alwar district, Khan, who claims to be over 100 years old, is mostly bedridden in his home nestled in the foothills of the Aravallis. He stays quiet...

-The Times of India NEW DELHI: In what is being seen as an attempt to delay launch of low priced generic medicines, multinational drug makers have asked the government to create a registry providing information about all drug applications pending manufacturing and marketing approval. The proposal, if accepted by the government, will help ‘big pharma’ pre-emptively challenge generic drug makers in court for allegedly infringing upon their patents and in turn blocking...